Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01390597
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 32
Early research (Phase 1)Study completedNCT02309580
What this trial is testing

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

Who this might be right for
T-cell LymphomaRelapsed and Refractory T-cell Lymphoma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT03776279
What this trial is testing

Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 106
Testing effectiveness (Phase 2)Ended earlyNCT06941688
What this trial is testing

Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (PTCL)
Seoul National University Hospital 17
Large-scale testing (Phase 3)Ended earlyNCT01420679
What this trial is testing

Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Spectrum Pharmaceuticals, Inc 21
Testing effectiveness (Phase 2)UnknownNCT04052659
What this trial is testing

Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 30
Not applicableLooking for participantsNCT07270861
What this trial is testing

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Who this might be right for
Peripheral T-Cell Lymphoma
Fudan University 3,000
Testing effectiveness (Phase 2)Study completedNCT01553786
What this trial is testing

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

Who this might be right for
T-cell Lymphoma
The Lymphoma Academic Research Organisation 80
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Early research (Phase 1)Study completedNCT01800838
What this trial is testing

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+4 more
Kevin Cooper MD 11
Testing effectiveness (Phase 2)Study completedNCT03936452
What this trial is testing

Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeEarly StageAnlotinib+5 more
Sun Yat-sen University 55
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Not applicableLooking for participantsNCT07248163
What this trial is testing

Universal CAR-T Cell Therapy for NHL

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Bioray Laboratories 6
Not applicableLooking for participantsNCT02840747
What this trial is testing

Tissue Repository: CTCL Collection Protocol

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphomatoid PapulosisSézary Syndrome
Columbia University 400
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Early research (Phase 1)Study completedNCT00077155
What this trial is testing

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Testing effectiveness (Phase 2)UnknownNCT03701022
What this trial is testing

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma
Peking University 61
Not applicableActive Not RecruitingNCT05237245
What this trial is testing

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)

Who this might be right for
Lymphoproliferation Induced by HTLV-1HTLV-1 Adult T-cell Lymphoma / LeukemiaHTLV-1 Infection
Assistance Publique - Hôpitaux de Paris 69
Post-approval studies (Phase 4)Study completedNCT05442554
What this trial is testing

Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

Who this might be right for
T-Cell Lymphoma
Takeda 10
Next Page